Trends in utilization of deceased donor kidneys based on hepatitis C virus status and impact of public health service labeling on discard

Venkatesh K. Ariyamuthu,Burhaneddin Sandikci,Nashila AbdulRahim,Christine Hwang,Malcolm P. MacConmara,Ravi Parasuraman,Ahsen Atis,Bekir Tanriover
DOI: https://doi.org/10.1111/tid.13204
2019-11-26
Transplant Infectious Disease
Abstract:<h3 class="article-section__sub-title section1"> Background</h3><p>Kidneys from deceased donors infected with hepatitis C virus (HCV) are underutilized. Most HCV virus‐infected donors are designated as Public Health Service increased donors (PHS‐IR). Impact of PHS and HCV designations on discard is not well studied.</p><h3 class="article-section__sub-title section1"> Methods</h3><p>We queried the UNOS dataset for all deceased donor kidneys between January 2015 and December 2018. The final study cohort donors (n= 38,702) were stratified into three groups based on HCV antibody (Ab) and NAT status: 1) Ab‐/NAT‐ (n= 35,861); 2) Ab+/NAT‐ (n= 973), and 3) Ab±/NAT+ (n=1,868). We analyzed utilization/discard rates of these organs, the impact of PHS‐IR and HCV designations on discard using multivariable two‐level hierarchical logistic regression models, forecasted number of HCV viremic donors/kidneys by 2023.</p><h3 class="article-section__sub-title section1"> Results</h3><p>During the study period, 1) the number of viremic donor kidneys increased 2 folds; 2) the multilevel mixed‐effects logistic regression models showed that, overall, the PHS labeling (OR 1.20, CI 95% CI 1.15‐1.29) and HCV designation (OR 2.29; 95% CI 2.15‐2.43) were independently associated with increased risk of discard; 3) contrary to the general perception, PHS‐non‐IR kidneys across all HCV groups, compared to PHS‐IR kidneys were more likely to be discarded; 4) we forecasted that the number of kidneys from HCV viremic donor kidneys might increase from 1,376 in 2019 to 2,092 in 2023.</p><h3 class="article-section__sub-title section1"> Conclusion</h3><p>HCV viremic kidneys might represent 10‐15% of deceased donor organ pool soon with the current rate of the opioid epidemic. PHS labeling effect on discard requires further discussion of the utility of this classification.</p>
immunology,infectious diseases,transplantation
What problem does this paper attempt to address?